[F-18]Flornaptitril for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Feb 2024: Trial registered, NCT06254469
  2. 1 Jul 2025: Trial started, NCT06254469

The trials

NCT06254469: Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease

State
Under way
Phase
Phase 3
People
230 planned
Started
1 Jul 2025
Primary completion
30 Jun 2028
Arms
Part B - AD, Part B - CTE
Results
None posted
  1. 12 Feb 2024: Trial registered
  2. 1 Jul 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.